ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Inhibition of BCR::ABL1 through SC or IM and ALKs through DOR shifted the CML cells into apoptosis, reducing the number of viable cells (Fig. 3A-i-ii).